NIH #1R01CA303137-01A1
Protein O' Mannosylation as a therapeutic vulnerability in KIAA1549-BRAF-driven pediatric low-grade glioma
- Amount
- $722K
- Period
- 2026-06-05 → 2031-05-31
- PIs
- 2
- Est. capacity / PI
- ~5 students
Awarded at DANA-FARBER CANCER INST
Glioma Diagnosis and Treatment · Genetics
1 total · 1 active
NIH #1R01CA303137-01A1
Awarded at DANA-FARBER CANCER INST
Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.
Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17
2026-06-17